Novartis tries texts to track supplies; China says 13% of capsulemakers were cheating;

> China's State Food and Drug Administration (SFDA) reports that 254 drug capsulemakers it inspected, which represent 12.7% of the industry, were manufacturing capsules that didn't meet standards. Story

> Novartis ($NVS) is leading a supply chain program in Tanzania that uses text messages to help manage malaria drug supplies in public health facilities. Item

> The manufacturers of two dozen drugs that failed quality tests by the Karnataka Drug Control Department in India have been ordered to make changes to their manufacturing. Story

> AptarGroup ($ATR) is buying Stelmi Group, which makes elastomer primary packaging components for injectable drug delivery. Release

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.